The FDA approved the Amplatzer PFO Occluder device to reduce stroke risk in patients who have had a stroke from a blood clot passing through a patent foramen ovale.
The FDA investigated the use of aspirin as a preventive method for heart attack and stroke in response to a petition to change the drug's prescribing information.
